Network Spectra for Drug-target Identification in Complex Diseases: New Guns Against Old Foes

Overview

Journal Appl Netw Sci

Date 2019 Jan 1

PMID 30596144

Citations 2

Authors

Aparna Rai

Pramod Shinde

Sarika Jalan

Affiliations

Soon will be listed here.

Abstract

The fundamental understanding of altered complex molecular interactions in a diseased condition is the key to its cure. The overall functioning of these molecules is kind of jugglers play in the cell orchestra and to anticipate these relationships among the molecules is one of the greatest challenges in modern biology and medicine. Network science turned out to be providing a successful and simple platform to understand complex interactions among healthy and diseased tissues. Furthermore, much information about the structure and dynamics of a network is concealed in the eigenvalues of its adjacency matrix. In this review, we illustrate rapid advancements in the field of network science in combination with spectral graph theory that enables us to uncover the complexities of various diseases. Interpretations laid by network science approach have solicited insights into molecular relationships and have reported novel drug targets and biomarkers in various complex diseases.

Citing Articles

Graph representation learning in biomedicine and healthcare.

Li M, Huang K, Zitnik M Nat Biomed Eng. 2022; 6(12):1353-1369.

PMID: 36316368 PMC: 10699434. DOI: 10.1038/s41551-022-00942-x.

Presentation of potential genes and deleterious variants associated with non-syndromic hearing loss: a computational approach.

Ray M, Rath S, Sarkar S, Sable M Genomics Inform. 2022; 20(1):e5.

PMID: 35399004 PMC: 9001992. DOI: 10.5808/gi.21070.

References

Watts D, Strogatz S . Collective dynamics of 'small-world' networks. Nature. 1998; 393(6684):440-2. DOI: 10.1038/30918. View

Barabasi A, Oltvai Z . Network biology: understanding the cell's functional organization. Nat Rev Genet. 2004; 5(2):101-13. DOI: 10.1038/nrg1272. View

Portela A, Esteller M . Epigenetic modifications and human disease. Nat Biotechnol. 2010; 28(10):1057-68. DOI: 10.1038/nbt.1685. View

Gottesman M . Mechanisms of cancer drug resistance. Annu Rev Med. 2002; 53:615-27. DOI: 10.1146/annurev.med.53.082901.103929. View

HAAKE , Zyczkowski . Random-matrix theory and eigenmodes of dynamical systems. Phys Rev A. 1990; 42(2):1013-1016. DOI: 10.1103/physreva.42.1013. View

Draghici S, Khatri P, Tarca A, Amin K, Done A, Voichita C . A systems biology approach for pathway level analysis. Genome Res. 2007; 17(10):1537-45. PMC: 1987343. DOI: 10.1101/gr.6202607. View

Banerjee A, Jost J . Spectral plots and the representation and interpretation of biological data. Theory Biosci. 2007; 126(1):15-21. DOI: 10.1007/s12064-007-0005-9. View

Cho D, Kim Y, Przytycka T . Chapter 5: Network biology approach to complex diseases. PLoS Comput Biol. 2013; 8(12):e1002820. PMC: 3531284. DOI: 10.1371/journal.pcbi.1002820. View

Kitano H . Systems biology: a brief overview. Science. 2002; 295(5560):1662-4. DOI: 10.1126/science.1069492. View

10.

Przulj N, Corneil D, Jurisica I . Modeling interactome: scale-free or geometric?. Bioinformatics. 2004; 20(18):3508-15. DOI: 10.1093/bioinformatics/bth436. View

11.

Wang Q, Liu W, Ning S, Ye J, Huang T, Li Y . Community of protein complexes impacts disease association. Eur J Hum Genet. 2012; 20(11):1162-7. PMC: 3476714. DOI: 10.1038/ejhg.2012.74. View

12.

. Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association. Diabetes Care. 1998; 21(2):296-309. DOI: 10.2337/diacare.21.2.296. View

13.

Gibson S, Ficklin S, Isaacson S, Luo F, Feltus F, Smith M . Massive-scale gene co-expression network construction and robustness testing using random matrix theory. PLoS One. 2013; 8(2):e55871. PMC: 3567026. DOI: 10.1371/journal.pone.0055871. View

14.

Rai A, Pradhan P, Nagraj J, Lohitesh K, Chowdhury R, Jalan S . Understanding cancer complexome using networks, spectral graph theory and multilayer framework. Sci Rep. 2017; 7:41676. PMC: 5290734. DOI: 10.1038/srep41676. View

15.

Koutsogiannouli E, Papavassiliou A, Papanikolaou N . Complexity in cancer biology: is systems biology the answer?. Cancer Med. 2013; 2(2):164-77. PMC: 3639655. DOI: 10.1002/cam4.62. View

16.

Shinde P, Sarkar C, Jalan S . Codon based co-occurrence network motifs in human mitochondria. Sci Rep. 2018; 8(1):3060. PMC: 5814444. DOI: 10.1038/s41598-018-21454-2. View

17.

Kelder T, van Iersel M, Hanspers K, Kutmon M, Conklin B, Evelo C . WikiPathways: building research communities on biological pathways. Nucleic Acids Res. 2011; 40(Database issue):D1301-7. PMC: 3245032. DOI: 10.1093/nar/gkr1074. View

18.

Zhu X, Gerstein M, Snyder M . Getting connected: analysis and principles of biological networks. Genes Dev. 2007; 21(9):1010-24. DOI: 10.1101/gad.1528707. View

19.

Fazekas D, Koltai M, Turei D, Modos D, Palfy M, Dul Z . SignaLink 2 - a signaling pathway resource with multi-layered regulatory networks. BMC Syst Biol. 2013; 7:7. PMC: 3599410. DOI: 10.1186/1752-0509-7-7. View

20.

Perfetto L, Briganti L, Calderone A, Cerquone Perpetuini A, Iannuccelli M, Langone F . SIGNOR: a database of causal relationships between biological entities. Nucleic Acids Res. 2015; 44(D1):D548-54. PMC: 4702784. DOI: 10.1093/nar/gkv1048. View